These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2959495)

  • 1. Decreased hematopoietic accessory cell function following bone marrow transplantation.
    Emerson SG; Sieff CA; Gross RG; Rozans MK; Miller RA; Rappeport JM; Nathan DG
    Exp Hematol; 1987 Nov; 15(10):1013-21. PubMed ID: 2959495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
    Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties.
    Linch DC; Lipton JM; Nathan DG
    J Clin Invest; 1985 Apr; 75(4):1278-84. PubMed ID: 3872887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT; Li SN; Champlin RE; Gale RP
    Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of hematopoiesis following bone marrow transplantation.
    Emerson SG; Gale RP
    Int J Cell Cloning; 1987 Nov; 5(6):432-49. PubMed ID: 3323328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods.
    Rozans MK; Smith BR; Burakoff SJ; Miller RA
    J Immunol; 1986 Jun; 136(11):4040-8. PubMed ID: 2939139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow adherent cell hemopoietic growth factor production.
    Quesenberry P; Song Z; Alberico T; Gualtieri R; Stewart M; Innes D; McGrath E; Cranston S; Kleeman E
    Prog Clin Biol Res; 1985; 184():247-56. PubMed ID: 3931091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
    Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
    J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of accessory cells in allogeneic peripheral blood stem cell transplantation.
    Tanaka J; Imamura M; Kasai M; Asaka M; Torok-Storb B
    Int J Hematol; 1999 Feb; 69(2):70-4. PubMed ID: 10071453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B-lymphocyte regulation of the functional activity of hematopoietic stem cells. I. The effect of activated B-lymphocytes from the murine spleen on the proliferation of syngeneic hematopoietic stem cells of the bone marrow].
    Man'ko VM; Choladze NV; Guseva OA; Sepiashvili RI; Iarilin AA
    Tsitologiia; 1996; 38(1):48-56. PubMed ID: 8768549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
    Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
    Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.